Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2021-11-17 Sale | 2021-11-19 3:34 pm | Trillium Therapeutics Inc. | TRIL | Walker Paul Edward Director | 5,736,363 | $0 | $0 | 0 (Indirect Direct) | View |
| 2021-11-17 Sale | 2021-11-19 1:30 pm | Trillium Therapeutics Inc. | TRIL | Harrison Rosemary See Remarks | 75 | $0 | $0 | 0 (Direct) | View |
| 2021-07-07 Sale | 2021-07-09 4:30 pm | Trillium Therapeutics Inc. | TRIL | Uger Robert Chief Scientific Officer | 3,646 | $9 | $32,814 | 102,083 (Direct) | View |
| 2021-06-07 Sale | 2021-06-09 4:23 pm | Trillium Therapeutics Inc. | TRIL | Uger Robert Chief Scientific Officer | 3,646 | $8.27 | $30,152 | 105,729 (Direct) | View |
| 2021-05-11 Sale | 2021-05-13 4:12 pm | Trillium Therapeutics Inc. | TRIL | Skvarka Jan President and CEO | 130,500 | $9.2083 | $1,201,683 | 1,580,302 (Direct) | View |
| 2021-05-07 Sale | 2021-05-11 4:24 pm | Trillium Therapeutics Inc. | TRIL | Uger Robert Chief Scientific Officer | 3,646 | $9.3 | $33,908 | 109,375 (Direct) | View |
| 2021-04-07 Sale | 2021-04-09 5:38 pm | Trillium Therapeutics Inc. | TRIL | Uger Robert Chief Scientific Officer | 3,646 | $10.82 | $39,450 | 113,021 (Direct) | View |
| 2021-04-08 Sale | 2021-04-09 5:23 pm | Trillium Therapeutics Inc. | TRIL | Petrova Penka Chief Development Officer | 5,312 | $11.09 | $58,910 | 133,440 (Direct) | View |
| 2021-03-12 Sale | 2021-03-15 5:12 pm | Trillium Therapeutics Inc. | TRIL | Uger Robert Chief Scientific Officer | 2,917 | $11.97 | $34,916 | 58,333 (Direct) | View |
| 2021-03-10 Sale | 2021-03-12 4:40 pm | Trillium Therapeutics Inc. | TRIL | Petrova Penka Chief Development Officer | 5,312 | $11.08 | $58,857 | 138,752 (Direct) | View |
| 2021-03-08 Sale | 2021-03-10 5:57 pm | Trillium Therapeutics Inc. | TRIL | Uger Robert Chief Scientific Officer | 3,646 | $10.11 | $36,861 | 116,667 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2021-07-07 Exercise | 2021-07-09 4:30 pm | N/A 2029-11-07 | Trillium Therapeutics Inc. | TRIL | Uger Robert Chief Scientific Officer | 3,646 | $0 | 102,083 (Direct) | View |
| 2021-07-07 Exercise | 2021-07-09 4:30 pm | N/A N/A | Trillium Therapeutics Inc. | TRIL | Uger Robert Chief Scientific Officer | 3,646 | $0.3039 | 102,083 (Direct) | View |
| 2021-07-01 Option Award | 2021-07-02 4:35 pm | N/A 2031-07-01 | Trillium Therapeutics Inc. | TRIL | MACKEY CATHERINE J Director | 67,000 | $0 | 67,000 (Direct) | View |
| 2021-06-07 Exercise | 2021-06-09 4:23 pm | N/A 2029-11-07 | Trillium Therapeutics Inc. | TRIL | Uger Robert Chief Scientific Officer | 3,646 | $0 | 105,729 (Direct) | View |
| 2021-06-07 Exercise | 2021-06-09 4:23 pm | N/A N/A | Trillium Therapeutics Inc. | TRIL | Uger Robert Chief Scientific Officer | 3,646 | $0.315 | 105,729 (Direct) | View |
| 2021-05-11 Exercise | 2021-05-13 4:12 pm | N/A 2029-09-25 | Trillium Therapeutics Inc. | TRIL | Skvarka Jan President and CEO | 130,500 | $0 | 1,580,302 (Direct) | View |
| 2021-05-11 Exercise | 2021-05-13 4:12 pm | N/A N/A | Trillium Therapeutics Inc. | TRIL | Skvarka Jan President and CEO | 87,500 | $0.4462 | 1,580,302 (Direct) | View |
| 2021-05-11 Exercise | 2021-05-13 4:12 pm | N/A N/A | Trillium Therapeutics Inc. | TRIL | Skvarka Jan President and CEO | 43,000 | $0.314 | 1,580,302 (Direct) | View |
| 2021-05-07 Exercise | 2021-05-11 4:24 pm | N/A 2029-11-07 | Trillium Therapeutics Inc. | TRIL | Uger Robert Chief Scientific Officer | 3,646 | $0 | 109,375 (Direct) | View |
| 2021-05-07 Exercise | 2021-05-11 4:24 pm | N/A N/A | Trillium Therapeutics Inc. | TRIL | Uger Robert Chief Scientific Officer | 3,646 | $0.313 | 109,375 (Direct) | View |
| 2021-05-03 Option Award | 2021-05-05 4:17 pm | N/A 2031-05-03 | Trillium Therapeutics Inc. | TRIL | Looker Benjamin General Counsel | 190,000 | $0 | 190,000 (Direct) | View |
| 2021-05-03 Option Award | 2021-05-05 4:16 pm | N/A 2031-05-03 | Trillium Therapeutics Inc. | TRIL | Myers Scott Dunseth Director | 67,000 | $0 | 67,000 (Direct) | View |
| 2021-04-07 Exercise | 2021-04-09 5:38 pm | N/A 2029-11-07 | Trillium Therapeutics Inc. | TRIL | Uger Robert Chief Scientific Officer | 3,646 | $0 | 113,021 (Direct) | View |
| 2021-04-07 Exercise | 2021-04-09 5:38 pm | N/A N/A | Trillium Therapeutics Inc. | TRIL | Uger Robert Chief Scientific Officer | 3,646 | $0.3012 | 113,021 (Direct) | View |
| 2021-04-08 Exercise | 2021-04-09 5:23 pm | N/A 2029-11-07 | Trillium Therapeutics Inc. | TRIL | Petrova Penka Chief Development Officer | 5,312 | $0 | 133,440 (Direct) | View |
| 2021-04-08 Exercise | 2021-04-09 5:23 pm | N/A N/A | Trillium Therapeutics Inc. | TRIL | Petrova Penka Chief Development Officer | 2,604 | $3.3638 | 133,440 (Direct) | View |
| 2021-04-08 Exercise | 2021-04-09 5:23 pm | N/A N/A | Trillium Therapeutics Inc. | TRIL | Petrova Penka Chief Development Officer | 2,708 | $0.3022 | 133,440 (Direct) | View |
| 2021-03-12 Exercise | 2021-03-15 5:12 pm | N/A 2028-11-08 | Trillium Therapeutics Inc. | TRIL | Uger Robert Chief Scientific Officer | 2,917 | $0 | 58,333 (Direct) | View |
| 2021-03-12 Exercise | 2021-03-15 5:12 pm | N/A N/A | Trillium Therapeutics Inc. | TRIL | Uger Robert Chief Scientific Officer | 2,917 | $3.3924 | 58,333 (Direct) | View |
| 2021-03-10 Exercise | 2021-03-12 4:40 pm | N/A 2029-11-07 | Trillium Therapeutics Inc. | TRIL | Petrova Penka Chief Development Officer | 5,312 | $0 | 138,752 (Direct) | View |
| 2021-03-10 Exercise | 2021-03-12 4:40 pm | N/A N/A | Trillium Therapeutics Inc. | TRIL | Petrova Penka Chief Development Officer | 2,604 | $3.3524 | 138,752 (Direct) | View |
| 2021-03-10 Exercise | 2021-03-12 4:40 pm | N/A N/A | Trillium Therapeutics Inc. | TRIL | Petrova Penka Chief Development Officer | 2,708 | $0.3012 | 138,752 (Direct) | View |
| 2021-03-08 Exercise | 2021-03-10 5:57 pm | N/A 2029-11-07 | Trillium Therapeutics Inc. | TRIL | Uger Robert Chief Scientific Officer | 3,646 | $0 | 116,667 (Direct) | View |
| 2021-03-08 Exercise | 2021-03-10 5:57 pm | N/A N/A | Trillium Therapeutics Inc. | TRIL | Uger Robert Chief Scientific Officer | 3,646 | $0.2999 | 116,667 (Direct) | View |